ADVERTISEMENT
Aarti Drugs Q4 Results: Profit Jumps 33%
The margin narrowed to 13.8% in the quarter ended March.
06 May 2025, 06:06 PM IST 
Save
.png?auto=format%2Ccompress&fmt=avif&mode=crop&ar=16%3A9&q=60)
Aarti Drugs Ltd. consolidated net profit grew 33% in the fourth quarter of the last financial year (Image: company website)
Show Quick Read
Summary is AI Generated. Newsroom Reviewed
Aarti Drugs Ltd. consolidated net profit grew 33% in the fourth quarter of the last financial year.
The pharmaceutical company posted a profit of Rs 63 crore in the quarter ended March, according to an exchange filing on Tuesday.
Aarti Drugs Q4 FY25 Highlights (Consolidated, YoY)
Revenue up 9% to Rs 676 crore versus Rs 620 crore.
Ebitda up 8% to Rs 93.2 crore versus Rs 86.1 crore.
Margin narrows to 13.8% versus 13.9%.
Net profit up 33% to Rs 63 crore versus Rs 47.4 crore.
Opinion
HPCL Q4 Results: Net Profit Rises 11%; Final Dividend Declared
Shares of Aarti Drugs closed 1.45% lower at Rs 349.9 apiece on the National Stock Exchange before the results were announced, compared to a 0.33% decline in the benchmark Nifty.
ALSO READ
Q4 Results: Mahanagar Gas Earnings Meet Estimates; BSE Profit More Than Doubles; NSE Earnings Down
Opinion
Q4 Results: Mahanagar Gas Earnings Meet Estimates; BSE Profit More Than Doubles; NSE Earnings Down
